A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

Slides:

Advertisements

Similar presentations

Summary Prepared by Melvyn Rubenfire, MD

Advertisements

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.

10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.

My Treatment Approach to Gout

Major recommendation for statin therapy for ASCVD prevention

25-Year Physical Activity Trajectories and Development of Subclinical Coronary Artery Disease as Measured by Coronary Artery Calcium: The Coronary Artery.

Cholesterol practice questions

From: Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular DiseaseGrand Rounds Discussion From the Beth Israel Deaconess Medical.

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know Siddharth Singh, MD, Kymberly D. Watt,

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention Erin D. Michos, MD, MHS, Michael J. Blaha,

Neil J. Stone et al. JACC 2014;63:

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Diagnostic Approach to the Complexity of IgG4-Related Disease

Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J

Jean L. Chan, MD, Martin J. Abrahamson, MD Mayo Clinic Proceedings

Treatment of Nightmares With Prazosin: A Systematic Review

Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,

Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative Philip A. Ades,

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Jari A. Laukkanen, MD, PhD, Tanjaniina Laukkanen, MSc, Setor K

Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,

Management of Adult Onset Seizures

My Treatment Approach to Gout

Can Vitamin D Deficiency Break Your Heart?

Understanding Palliative Care and Hospice

Gestational Trophoblastic Disease

Topical Analgesics in the Management of Acute and Chronic Pain

Cardiorespiratory Fitness: An Independent and Additive Marker of Risk Stratification and Health Outcomes Barry A. Franklin, PhD, Peter A. McCullough,

The Organ Transplant Imperative

Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival Barry A. Franklin, PhD Mayo Clinic Proceedings

James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D.

Cardiovascular disease in women with HIV-1 infection

Ali A. Hasnie, MD, Ashok Kumbamu, PhD, Maya S

Contemporary Evidence-Based Guidelines

Metastatic Breast Cancer

Pancreatic Ductal Adenocarcinoma

Barbara P. Yawn, MD, MSc, MSPH, MeiLan K. Han, MD, MS

2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation: Physiologic and Educational Rationale for Changes Roger D. White, MD Mayo.

Rajiv Chhabra, MD, James H

Khurram Nasir et al. JACC 2015;66:

R. Scott Wright, MD, Stephen L. Kopecky, MD, Guy S. Reeder, MD

Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families LaTonya J. Hickson,

MIGUEL A. VALDOVINOS, M. D. , MICHAEL CAMILLERI, M. D. , BRUCE R

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention Abdallah Al-Salameh, MD, Philippe Chanson,

A Perspective on the New American College of Cardiology/American Heart Association Guidelines for Cardiovascular Risk Assessment Iftikhar J. Kullo, MD,

Management of Adult Onset Seizures

Evaluation and Management of Penicillin Allergy

Institutional Review Boards: What Clinician Researchers Need to Know

Diabetic Mastopathy Mayo Clinic Proceedings

Rhanderson Cardoso, MD, Roger S

Novel Risk Factors for Atherosclerosis

Allen D. Seftel, MD, Martin Kathrins, MD, Craig Niederberger, MD

Hepatocellular Carcinoma

Counseling Patients on the Use of Electronic Cigarettes

Postoperative Trouble

Medical Treatment of Overactive Bladder: In Response

Ross Arena, PhD, PT, FAHA, Carl J. Lavie, MD Mayo Clinic Proceedings

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

Squamous Cell Carcinoma of the Tongue

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy? Elias Jabbour, MD, Jorge E. Cortes,

Current Concepts in Laboratory Testing to Guide Antimicrobial Therapy

Medical Student Distress: Causes, Consequences, and Proposed Solutions

Cindy A. Kermott, MD, MPH, Darrell R. Schroeder, MS, Stephen L

Diagnosis and Management of Headache in Older Adults

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

Presentation transcript:

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps Francisco Lopez-Jimenez, MD, MSc, Vinaya Simha, MD, Randal J. Thomas, MD, MSc, Thomas G. Allison, PhD, MPH, Ananda Basu, MD, Regis Fernandes, MD, R. Todd Hurst, MD, Stephen L. Kopecky, MD, Iftikhar J. Kullo, MD, Sharon L. Mulvagh, MD, Warren G. Thompson, MD, Jorge F. Trejo-Gutierrez, MD, MHS, R. Scott Wright, MD Mayo Clinic Proceedings Volume 89, Issue 9, Pages 1257-1278 (September 2014) DOI: 10.1016/j.mayocp.2014.06.016 Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure Proposed algorithm when considering initiating statins for cholesterol treatment in atherosclerotic cardiovascular disease (ASCVD) risk reduction. ABI = ankle-brachial index; AHA = American Heart Association; CAD = coronary artery disease; CV = cardiovascular; DM = diabetes mellitus; HF = heart failure; HIV = human immunodeficiency virus; LDL-C = low-density lipoprotein cholesterol; NYHA = New York Heart Association; RCT = randomized controlled trial; Rx = treatment; TLC = therapeutic lifestyle change. Mayo Clinic Proceedings 2014 89, 1257-1278DOI: (10.1016/j.mayocp.2014.06.016) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions